drugset / Trial / NCT02276365
Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the study was to investigate whether there is a drug-drug interaction between BI 10773 and pioglitazone when co-administered as multiple oral doses. Therefore, the relative bioavailabilities of BI 10773 and pioglitazone were determined when both drugs were given in combination compared with BI 10773 and pioglitazone given alone.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 50 mg | Oral |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |
Indications
No indication recorded.